There was no significant shift in the distribution of @-day disability outcomes on the global modified Rankin scale between patients in the magnesium group and those in the placebo group ( P = @ by the Cochran-Mantel-Haenszel test ) ; mean scores at @ days did not differ between the magnesium group and the placebo group ( @ in each group , P = @ ) .